MENU
DMAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

DiaMedica Therapeutics (DMAC) Earnings Date & Reports

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

DMAC is expected to report earnings to rise 9.28% to -19 cents per share on November 05

DiaMedica Therapeutics DMAC Stock Earnings Reports
Q3'25
Est.
$-0.20
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.01
The last earnings report on August 12 showed earnings per share of -18 cents, beating the estimate of -18 cents. With 125.55K shares outstanding, the current market capitalization sits at 311.68M.
View a ticker or compare two or three
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DMAC showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
19
Web
https://www.diamedica.com